Major progress in understanding progression in chronic myeloid leukemia

Jerry Radich

首页> 外文期刊>The Journal of Experomental Medicine >Major progress in understanding progression in chronic myeloid leukemia

【24h】

Major progress in understanding progression in chronic myeloid leukemia

机译：在了解慢性粒细胞白血病进展方面的重大进展

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

![Figure][1]/imgInsight from Jerry RadichAt last, a mouse model of the natural history of chronic myeloid leukemia (CML) has been elegantly engineered.CML is hardly a public health menace, occurring in only 1–2 per 100,000 people. Nonetheless, the disease is the “poster child” of

机译：！[图] [1] Jerry Radich的见解最后，对慢性髓性白血病（CML）自然病史的小鼠模型进行了精心设计。CML几乎不是一种公共卫生威胁，仅发生于1-2次每十万人。但是，这种疾病是

著录项

来源
《The Journal of Experomental Medicine》 |2015年第10期|共4页
作者
Jerry Radich;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医用一般科学;
关键词

相似文献

外文文献
中文文献
专利

1. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV [J] . Christian Michel, Andreas Burchert, Andreas Hochhaus, Haematologica . 2019,第5期

机译：伊马替尼剂量减少对慢性粒细胞白血病的主要分子反应：德国慢性粒细胞白血病的研究IV
2. Assessing the Clinical Significance of Major (MMR) and Deep (DMR) Molecular Responses for Overall (OS), Progression-Free (PFS) and Event-Free (EFS) Survival in Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs) [J] . Viana Ricardo, Mojebi Ali, Aimone Paola, Clinical lymphoma, myeloma & leukemia . 2019,第Suppla1期

机译：评估用酪氨酸激酶抑制剂治疗的慢性髓性白血病（CML）患者的主要（MMR）和深（OS），无进展（PFS）和无事项（EFS）存活的临床意义（MMR）分子应答（TKIS）
3. Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia [J] . G Heller, T Topakian, C Altenberger, Leukemia . 2016,第9期

机译：下一代测序可确定Ph +慢性粒细胞白血病进展过程中的主要DNA甲基化变化
4. Dynamical modeling of chronic myeloid leukemia progression and the development of mutations [C] . Zhang Ben-gong, Tanaka Gouhei, Chen Luonan, 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops. . 2012

机译：慢性粒细胞白血病进展和突变发展的动力学模型
5. New strategies for targeted chronic myeloid leukemia therapy: Disrupting BCR-ABL1 dimerization and secondary leukemia-specific pathways [D] . Woessner, David W. 2013

机译：针对性慢性粒细胞白血病治疗的新策略：破坏BCR-ABL1二聚化和继发性白血病特异性途径
6. Major progress in understanding progression in chronic myeloid leukemia [O] . Jerry Radich 2015

机译：在了解慢性粒细胞白血病进展方面的重大进展
7. Transformation from atypical chronic myeloid leukemia to chronic myelomonocytic leukemia as progression of myeloid neoplasm with platelet-derived growth factor ß rearrangement [O] . Xue Shi, Zhan Su, Chunting Zhao, 2015

机译：从非典型慢性粒细胞白血病转变为慢性粒单核细胞白血病作为髓样肿瘤的进展与血小板衍生生长因子β重排

Major progress in understanding progression in chronic myeloid leukemia

摘要

著录项

相似文献

相关主题

期刊订阅